Studies linking statins to diabetes receive media attention but should not distract clinicians from the goal of reducing cardiovascular risk. Almost eight years after the Food and Drug Administration (FDA) added a warning to statin labels about the drugs increasing fasting blood sugar and hemoglobin A1C levels — and by inference raising the risk of […]
